Chronic cerebral hypoperfusion induces white matter lesions and loss of oligodendroglia with DNA fragmentation in the rat. - Wikidata - wikimedia - TriplyDB

Chronic cerebral hypoperfusion induces white matter lesions and loss of oligodendroglia with DNA fragmentation in the rat.

Chronic cerebral hypoperfusion induces white matter lesions and loss of oligodendroglia with DNA fragmentation in the rat.

http://www.wikidata.org/entity/Q31166365

about

Restoration of oligodendrocyte pools in a mouse model of chronic cerebral hypoperfusion Age-related changes of the oligodendrocytes in rat subcortical white matter Delays in auditory-cued step initiation are related to increased volume of white matter hyperintensities in older adults The neuron-astrocyte-microglia triad in a rat model of chronic cerebral hypoperfusion: protective effect of dipyridamole.Hypoxia-induced neuroinflammatory white-matter injury reduced by minocycline in SHR/SP.Chronic cerebral hypoperfusion induces vascular plasticity and hemodynamics but also neuronal degeneration and cognitive impairment Dicholine salt of succinic acid, a neuronal insulin sensitizer, ameliorates cognitive deficits in rodent models of normal aging, chronic cerebral hypoperfusion, and beta-amyloid peptide-(25-35)-induced amnesia Focal cerebral ischemia in the TNFalpha-transgenic rat.Apolipoprotein E ε4: A Possible Risk Factor of Intracranial Pressure and White Matter Perfusion in Good-Grade Aneurysmal Subarachnoid Hemorrhage Patients at Early Stage.Cerebral hypoperfusion in multiple sclerosis is reversible and mediated by endothelin-1.Heterogeneity in mild cognitive impairment: differences in neuropsychological profile and associated white matter lesion pathology MRI features of Binswanger's disease predict prognosis and associated pathology Metzincin proteases and their inhibitors: foes or friends in nervous system physiology?Catechol-O-methyltransferase Val158Met polymorphism on the relationship between white matter hyperintensity and cognition in healthy people.Brain hypoperfusion: a critical factor in vascular dementia.Fructus mume extracts alleviate cognitive impairments in 5XFAD transgenic mice Effects of Fructus mume Extract on MAPK and NF-κB Signaling and the Resultant Improvement in the Cognitive Deficits Induced by Chronic Cerebral Hypoperfusion.Subcortical ischemic vascular disease: Roles of oligodendrocyte function in experimental models of subcortical white-matter injury.The TNFα-Transgenic Rat: Hippocampal Synaptic Integrity, Cognition, Function, and Post-Ischemic Cell Loss.Mucosal tolerization to E-selectin protects against memory dysfunction and white matter damage in a vascular cognitive impairment model.Divergent role for MMP-2 in myelin breakdown and oligodendrocyte death following transient global ischemia.Protective effects of cilostazol against transient focal cerebral ischemia and chronic cerebral hypoperfusion injury.The clinical manifestations and pathophysiology of cerebral small vessel disease Serial expression of hypoxia inducible factor-1α and neuronal apoptosis in hippocampus of rats with chronic ischemic brain.Alternations of Septal-hippocampal System in the Adult Wistar Rat with Spatial Memory Impairments Induced by Chronic Cerebral Hypoperfusion.Gradual cerebral hypoperfusion in spontaneously hypertensive rats induces slowly evolving white matter abnormalities and impairs working memory.Dl-3-n-Butylphthalide Treatment Enhances Hemodynamics and Ameliorates Memory Deficits in Rats with Chronic Cerebral Hypoperfusion.Citicoline protects against cognitive impairment in a rat model of chronic cerebral hypoperfusion Changes of hypoxia-inducible factor-1 signaling and the effect of cilostazol in chronic cerebral ischemia.Cerebral Small Vessel Disease Is Associated with Dysregulation in the Ubiquitin Proteasome System and Other Major Cellular Pathways in Specific Brain Regions.Ameliorating Effects of Ethanol Extract of Fructus mume on Scopolamine-Induced Memory Impairment in Mice.Effect of benzodiazepine hypnotic triazolam on relationship of blood pressure and Paco2 to cerebral blood flow during human non-rapid eye movement sleep.Extracorporeal shock wave therapy effectively protects brain against chronic cerebral hypo-perfusion-induced neuropathological changes.Melatonin attenuated the brain damage and cognitive impairment partially through MT2 melatonin receptor in mice with chronic cerebral hypoperfusion.Physical Exercise Improves Cognitive Function Together with Microglia Phenotype Modulation and Remyelination in Chronic Cerebral Hypoperfusion.Small artery dementia in Japan: radiological differences between CADASIL, leukoaraiosis and Binswanger's disease.White matter degeneration in vascular and other ageing-related dementias.Association of Cardiac Hemodynamic Factors With Severity of White Matter Hyperintensities in Chronic Valvular Heart Disease.Neuroprotective effect of berberine chloride on cognitive impairment and hippocampal damage in experimental model of vascular dementia.Advances in chronic cerebral circulation insufficiency.

P2860

Q27325132-15D52E96-45B6-4A19-AA70-CADA7DCE1266 Q28579595-49FDEF38-5011-415C-A544-BF6F45CF95A2 Q30488517-FD40B53D-A72E-4F42-A719-5CDE494C520D Q30602337-6D1E851E-13A8-44BB-A9A1-3B0A4BE22273 Q30899226-7DC09EFD-06F6-4EA0-BC91-263D80C32B0E Q30927208-0D26EF22-7107-47EB-B301-6BF0F6E7A16E Q33316237-479DA036-D001-47B3-9E04-25A9427721A6 Q33378976-39D0379B-8D80-4356-A82A-B0F0A213AC61 Q33575923-E4083973-5A94-4FE7-AAC6-9A98268D5171 Q34333921-AFEC0080-0265-4DF0-930A-BD9965286C45 Q34556136-B3D6155A-1E39-4EE4-B20F-AA94EB8D2BBB Q34562869-D57E687F-CBB3-46C7-8610-FA0B363ABE1A Q34768858-8EF4C11D-616F-45AD-AF45-6C8EAE0F89B1 Q35097521-26745AAB-CE9E-41B4-9048-DA3EE7A670A9 Q35841696-19CF62A1-403B-4319-BDAF-C418FFCEA8C5 Q35916667-637041C9-33DF-4736-80EF-D94CCCC4CF83 Q36537983-ED5275AF-59FB-45AA-A842-45E8B8EF1BE4 Q36593234-F0A725C9-5788-4741-A71E-0DFD8D8D246D Q36868735-A7EE2EFF-BCD7-4AD3-A862-35CF1DAE4B48 Q37012747-79D6CEDB-766A-440B-A0AB-81D108BC560C Q37108870-D6B9035F-F433-4AF2-8EAC-84BB87FD338B Q37164669-33462785-9B8A-40D7-8B4D-7629203EBBF6 Q37760792-6758884D-4AFB-441E-9A59-AC3DE504E019 Q38465534-8AC2D6AE-8959-4FC0-BCD8-15B6A5B61ABE Q39034775-7E9C6C47-8833-4989-AC26-A8239FC5D97B Q41022786-DBE03F20-A86B-4594-A489-63CB6FCF1BA6 Q41123114-3B9B2557-6F9B-4EBB-894B-85D66B69E308 Q41858548-DD6A05BC-0310-4DE8-94B5-C1D5542416B3 Q42120491-6A925B2F-1A19-40A9-98ED-9ED22EBC3410 Q42513691-1B9BE91F-7A20-4E43-8640-495DDC18E2F8 Q43150793-A6B55CF3-DA17-4578-BA1E-A685B02A65E7 Q46776061-167CA495-9DD1-4BF4-850A-690CFE1654A2 Q47120650-B9B94031-94B7-4096-9E9C-7FB7BA437DC3 Q47146884-A0D75FA3-8335-438B-8293-B608BFB1AAB4 Q47222203-59878F34-FC87-4D69-A712-3616F5997070 Q47230857-EADD540D-9172-495E-B83F-6D54114DF0E1 Q47325037-68085AEF-AFA0-4410-A185-26D99AD7DA3E Q47427995-7AE56CCD-980C-40EC-9ED2-35200438344A Q47700141-3B4E052E-5DBA-40DD-9D49-32175E534670 Q47967225-6C6877AB-97AB-4F27-B1F1-0E8A017D3018

P2860

Chronic cerebral hypoperfusion induces white matter lesions and loss of oligodendroglia with DNA fragmentation in the rat.

http://www.wikidata.org/entity/Q31166365

description

2003 nî lūn-bûn

@nan

2003 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

Chronic cerebral hypoperfusion ...... DNA fragmentation in the rat.

@ast

Chronic cerebral hypoperfusion ...... DNA fragmentation in the rat.

@en

type

label

Chronic cerebral hypoperfusion ...... DNA fragmentation in the rat.

@ast

Chronic cerebral hypoperfusion ...... DNA fragmentation in the rat.

@en

prefLabel

Chronic cerebral hypoperfusion ...... DNA fragmentation in the rat.

@ast

Chronic cerebral hypoperfusion ...... DNA fragmentation in the rat.

@en

P1433

Q31166365-D7B4316F-604D-4E29-AD95-F905BDB31541

P1476

Q31166365-D097470C-F3A5-48D4-ACF8-3E7BB9199FF7

P2093

Q31166365-0CB020DD-B166-488D-BE40-A5908846F1F6

Q31166365-23D3C100-CB04-4C8B-96FE-8B7BFEBE5805

Q31166365-2B161B65-089B-4DCC-9218-F5BD599A2DAB

Q31166365-3FEDF62C-5391-4C26-8D5D-79EAA7C2B672

Q31166365-977A52FE-D570-4E07-BFAF-FFA7706A8BDB

Q31166365-A8820356-DCF3-40AD-9468-A2B6C3BB8D2D

Q31166365-C0B99F92-8A01-49F9-A3AB-4D76F087779F

Q31166365-F36D1B88-48D4-4162-A51B-AE489C7C7BBF

P2888

Q31166365-25EBB73F-C191-4991-8137-B65F50F52ED5

P304

Q31166365-2F24722B-84DD-4CB1-906B-4D675277358C

P31

Q31166365-7DF5082E-4AD1-4A82-BF6C-4023FBBCA731

P356

Q31166365-1F4DBC77-0E15-4435-9C47-23D5D73434B1

P433

Q31166365-E1CA2C4A-9283-487E-814D-E50EBB2DCF01

P478

Q31166365-1BA07CA6-3E2F-4FE8-924E-1775E59FF3A3

P577

Q31166365-0FEF1EDD-7FA7-478F-9F4C-F15651189271

P6179

Q31166365-0123002F-809B-42CB-9F6A-116DFF0AC75E

P698

Q31166365-8B9A92B2-C851-45CD-9040-696D166CA723

P921

Q31166365-7CFBC42D-1E39-4F10-A8AC-0DA40AA7D0E0

Q31166365-D4389517-994B-45B6-ACE9-1A332F44CB2E

P356

S00401-003-0749-3

P1433

Acta Neuropathologica

P1476

Chronic cerebral hypoperfusion ...... DNA fragmentation in the rat.

@en

P2093

Akiguchi I

http://www.w3.org/2001/XMLSchema#string

Ihara M

http://www.w3.org/2001/XMLSchema#string

Kinoshita M

http://www.w3.org/2001/XMLSchema#string

Lin JX

http://www.w3.org/2001/XMLSchema#string

Ohtani R

http://www.w3.org/2001/XMLSchema#string

Shibasaki H

http://www.w3.org/2001/XMLSchema#string

Tomimoto H

http://www.w3.org/2001/XMLSchema#string

Wakita H

http://www.w3.org/2001/XMLSchema#string

P2888

s00401-003-0749-3

P304

527-534

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00401-003-0749-3

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

106

http://www.w3.org/2001/XMLSchema#string

P577

2003-09-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1027468349

http://www.w3.org/2001/XMLSchema#string

P698

13680276

http://www.w3.org/2001/XMLSchema#string

P921

oligodendrocyte